Less Ads, More Data, More Tools Register for FREE

Pin to quick picksScience Sprt Regulatory News (SIS)

  • This share is currently suspended. It was suspended at a price of 33.50
  • There is currently no data for SIS

Half Year Trading Update

30 Sep 2013 07:00

RNS Number : 1662P
Science in Sport PLC
30 September 2013
 



For immediate release

30 September 2013

 

SCIENCE IN SPORT PLC

("SiS" or the "Company")

 

Half Year Trading Update

Science in Sport plc (AIM: SIS), a leading sports nutrition company, is pleased to announce the following pre-close trading update ahead of its financial results for the half year ended 30 September 2013.

The Board is pleased to report another period of significant revenue growth with sales expected to be up 23 per cent, compared with the same period last year, at approximately £3.95 million.

Revenue growth in the half year has been driven by strong sales of isotonic gels, food bars and hydration tablets and reflects the Company's on-going investment in product innovation, sales and marketing.

The revenue growth highlights the strength of the SiS brand and the resilience of the sports nutrition category. The growth was evident in all channels including major grocers, high street outlets, independent retailers and e-commerce, as well as in international markets.

Pre-tax profits for the half year are expected to be in line with management expectations and the Board remains confident of the outlook for continued revenue growth in the full year.

Science in Sport intends to issue its half year results in early December 2013.

 

For further information:

Science in Sport PLC

+44 (0) 1753 861722

Stephen Moon, CEO

Cenkos Securities

+44 (0) 20 7397 8900

Bobbie Hilliam - NOMAD and Broker

Buchanan

+44 (0) 20 7466 5000

Mark Court / Sophie McNulty / Fiona Henson

sis@buchanan.uk.com

 

About Science in Sport plc

Science in Sport plc is a leading sports nutrition company that develops, manufactures and markets sports nutrition products for professional athletes and sports enthusiasts. SiS is a strong brand in the elite athlete community - in the 2012 London Olympics, 24 medal-winning athletes or teams used SiS products.

The SiS core product ranges include: SiS GO, comprising energy powders, isotonic gels, energy bars and hydration tablets; and SiS REGO, including protein-based recovery powders and bars. SiS products are sold in a range of retail channels, including specialist sport retailers, major grocers, high street retailers and e-commerce websites.

SiS is currently the official sports nutrition supplier to cycling teams Rapha Condor JLT, Belkin Pro Cycling, Madison Genesis, Pro Team Astana and Team Katusha. SiS is also currently the official supplier of sports drinks and sports nutrition to the GB Rowing Team. Mark Cavendish, the Manx Missile, is an elite sports consultant and Olympians Sir Chris Hoy, Helen Jenkins and Rebecca Romero are official brand ambassadors.

SiS was founded in 1992 and is headquartered in Windsor, Berkshire. Its manufacturing facility is in Nelson, Lancashire.

SiS shares are traded on the AIM market of the London Stock Exchange under the ticker symbol SIS.

For further information, please visit www.scienceinsport.com

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCLLFVEAFIDFIV
Date   Source Headline
29th Jul 202412:05 pmRNSTR-1: Notification of Major Holdings
29th Jul 202410:02 amRNSTR-1: Notification of Major Holdings
26th Jul 202411:52 amRNSTR-1: Notification of Major Holdings
24th Jul 202412:43 pmRNSResult of General Meeting and Total Voting Rights
16th Jul 202410:26 amRNSTR-1: Notification of Major Holdings
16th Jul 202410:11 amRNSTR-1: Notification of Major Holdings
16th Jul 202410:10 amRNSTR-1: Notification of Major Holdings
9th Jul 20249:20 amRNSDirector/PDMR Shareholding
8th Jul 20242:16 pmRNSDirector/PDMR Shareholding
8th Jul 20241:36 pmRNSPosting of Circular and notice of General Meeting
8th Jul 20247:00 amRNSResult of the Retail Offer
5th Jul 202412:38 pmRNSDirector/PDMR Shareholding
5th Jul 20247:01 amRNSManagement Incentive Plan
5th Jul 20247:00 amRNSResult of Placing and director dealings
4th Jul 20245:10 pmRNSRetail Offer for up to £0.5 million
4th Jul 20245:04 pmRNSProposed Placing and Retail Offer
1st Jul 20247:00 amRNSNominated Adviser and Broker
28th Jun 20243:42 pmRNSAnnual Report and Notice of Annual General Meeting
28th Jun 20247:00 amRNSFinal Results for the Year Ended 31 December 2023
28th Jun 20247:00 amRNSHalf Year Trading Update and Board Changes
12th Jun 20247:00 amRNSNotice of Results
21st May 20247:00 amRNSNotification of Major Holdings
20th May 20247:00 amRNSNotification of Major Holdings
20th May 20247:00 amRNSNotification of Major Holdings
15th May 202410:35 amRNSNotification of Major Holdings
14th May 202411:20 amRNSNotification of Major Holdings
6th Mar 20247:00 amRNSTrading Update
5th Jan 20247:00 amRNSDirector/PDMR Shareholding
5th Jan 20247:00 amRNSNotification of Major Holdings
29th Dec 202311:20 amRNSIssue of Equity and Total Voting Rights
19th Oct 20237:00 amRNSDirectorate Change
16th Oct 20237:00 amRNSBoard Changes
28th Sep 202310:30 amRNSInterim Results - Replacement
28th Sep 20237:00 amRNSAppointment of Non Exec Chairman
28th Sep 20237:00 amRNSInterim Results
28th Jul 20232:58 pmRNSResult of Annual General Meeting
28th Jul 20237:00 amRNSBoard changes
10th Jul 20237:00 amRNSDirector/PDMR Shareholding
5th Jul 20233:49 pmRNSTR-1: Notification of Major Holdings
5th Jul 20237:00 amRNSBoard Change and Notice of AGM
4th Jul 20237:30 amRNSRestoration - Science in Sport PLC
4th Jul 20237:00 amRNSRestoration of Trading & Posting of Annual Report
3rd Jul 20237:30 amRNSSuspension - Science In Sport Plc
3rd Jul 20237:00 amRNSTemporary Suspension
29th Jun 202310:38 amRNSReplacement RNS - Preliminary Results
29th Jun 20237:00 amRNSFinal results
28th Jun 202310:43 amRNSNotification of Major Holdings
23rd Jun 20237:00 amRNSNotice of Final Results
2nd May 20233:33 pmRNSAIM Rule 17 / Schedule 2(g) Update
18th Apr 20237:00 amRNSInvestor Site Visit

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.